Cargando…

The alpha-glucosidase inhibitor miglitol increases hepatic CYP7A1 activity in association with altered short-chain fatty acid production in the gut of obese diabetic mice

PURPOSE: Bile acids (BAs) have been shown to contribute to glucose and energy homeostasis. We have recently reported that miglitol, an alpha-glucosidase inhibitor, increases fecal BA excretion and ameliorate insulin resistance and obesity in mice. The aim of this study was to clarify the mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamada, Yoji, Goto, Moritaka, Nishimura, Go, Nagasaki, Hiroshi, Seino, Yusuke, Kamiya, Hideki, Nakamura, Jiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424806/ https://www.ncbi.nlm.nih.gov/pubmed/32812937 http://dx.doi.org/10.1016/j.metop.2020.100024

Ejemplares similares

Distinct action of the α-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion
por: Lee, Eun Young, et al.
Publicado: (2015)

Switching α-Glucosidase Inhibitors to Miglitol Reduced Glucose Fluctuations and Circulating Cardiovascular Disease Risk Factors in Type 2 Diabetic Japanese Patients
por: Hariya, Natsuyo, et al.
Publicado: (2014)

Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice
por: Himeno, Tatsuhito, et al.
Publicado: (2011)

Stability-Indicating RP-HPLC Method for Estimation of Miglitol in Bulk and Tablets
por: Shrivastava, B., et al.
Publicado: (2010)

Effect of the Addition of Sitagliptin and Miglitol on Insulin-Treated Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2012)

Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
por: Kubo, Sayaka, et al.
Publicado: (2010)

Review: Miglitol has potential as a therapeutic drug against obesity
por: Sugimoto, Satoru, et al.
Publicado: (2015)

Incretin Kinetics Before and After Miglitol in Japanese Patients With Late Dumping Syndrome
por: Amagai, Mari, et al.
Publicado: (2017)

Peptide modulators of alpha-glucosidase
por: Roskar, Irena, et al.
Publicado: (2015)

Tumor‐like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin‐induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat
por: Hayami, Tomohide, et al.
Publicado: (2020)

Kinetic Determination of Acarbose and Miglitol in Bulk and Pharmaceutical Formulations Using Alkaline Potassium Permanganate
por: Ibrahim, F. A., et al.
Publicado: (2007)

α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study
por: Shimabukuro, Michio, et al.
Publicado: (2017)

Development and Validation of Miglitol and Its Impurities by RP-HPLC and Characterization Using Mass Spectrometry Techniques
por: Balakumaran, Kesavan, et al.
Publicado: (2016)

Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model
por: Kishida, Yumi, et al.
Publicado: (2017)

Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor‐deficient mice
por: Okawa, Tetsuji, et al.
Publicado: (2014)

Association of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients
por: Nakashima, Eitaro, et al.
Publicado: (2010)

Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus
por: Nomura, Shosaku, et al.
Publicado: (2011)

Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia
por: Kitano, Daisuke, et al.
Publicado: (2013)

Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial
por: Iijima, Takahiro, et al.
Publicado: (2020)

Ingestion of a moderate high‐sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon‐like peptide‐1 secretion
por: Sakamoto, Eriko, et al.
Publicado: (2012)

Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas
por: Hsieh, Sheng-Hwu, et al.
Publicado: (2010)

Effects of Miglitol, Acarbose, and Sitagliptin on Plasma Insulin and Gut Peptides in Type 2 Diabetes Mellitus: A Crossover Study
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report
por: Nishimura, Takuya, et al.
Publicado: (2014)

Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
por: van de Laar, Floris Alexander
Publicado: (2008)

Inhibitory Properties of Aqueous Ethanol Extracts of Propolis on Alpha-Glucosidase
por: Zhang, Hongcheng, et al.
Publicado: (2015)

Alpha Glucosidase Inhibitory Activities of Plants with Focus on Common Vegetables
por: Assefa, Samuel Tilahun, et al.
Publicado: (2019)

Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
por: Devaraj, Surabhi, et al.
Publicado: (2021)

Intestinal Production of Alpha-Glucosidase Inhibitor by Bacillus coagulans Spores
por: Kim, Hee-Woong, et al.
Publicado: (2023)

Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?
por: Himeno, Tatsuhito, et al.
Publicado: (2018)

Different trends in causes of death in patients with diabetes between Japan and the USA
por: Tsunekawa, Shin, et al.
Publicado: (2018)

Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

Not out of the woods yet: “Diabetic neuropathy” or “neuropathy associated with diabetes”?
por: Himeno, Tatsuhito, et al.
Publicado: (2022)

Inhibitory effects of pu-erh tea on alpha glucosidase and alpha amylase: a systemic review
por: Yang, Chiung-Ying, et al.
Publicado: (2019)

Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes
por: Kondo, Masaki, et al.
Publicado: (2015)

Inhibitory activity of Euonymus alatus against alpha-glucosidase in vitro and in vivo
por: Lee, Soo-Kyung, et al.
Publicado: (2007)

Alpha-Glucosidase Inhibitory Diterpenes from Euphorbia antiquorum Growing in Vietnam
por: Tran, Cong-Luan, et al.
Publicado: (2021)

Screening of Aqueous Extract of Persea americana Seeds for Alpha-Glucosidase Inhibitors
por: Lawal, Tajudeen Afolayan
Publicado: (2022)

Pneumatosis Intestinalis Induced by Alpha-Glucosidase Inhibitors in Patients with Diabetes Mellitus
por: McKinley, Blake J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8hi9vg8kbfcbodup9djn0b4qcd